ArticleTherapeutics and clinical risk management2025
Serum Periostin as a Novel Biomarker for Predicting 30-Day Major Adverse Cardiac Events After Off-Pump Coronary Artery Bypass Grafting.
Qian Su et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.